ABCL vs NFLX · rev $12.4M vs P/E 25, rev $12.56B
Abcellera Biologics Inc (ABCL) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Latest reported ABCL revenue for 2026-06-30 was $12.4M. Net income was -$98.6M. Revenue was up 48.7% from 2026-03-31 to 2026-06-30. ABCL currently screens at market cap $1.12B.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
ABCL currently screens at market cap $1.12B. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the ABCL and NFLX stock pages for the full models.
Not investment advice.